Acelrx Pharmaceuticals Inc. Stock
A loss of -1.880% shows a downward development for Acelrx Pharmaceuticals Inc..
Our community is currently high on Acelrx Pharmaceuticals Inc. with 3 Buy predictions and 1 Sell predictions.
With a target price of €4.00 there is potential for a 219.744% increase which would mean more than doubling the current price of €1.25 for Acelrx Pharmaceuticals Inc..
Our community identified positive and negative aspects for Acelrx Pharmaceuticals Inc. stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Acelrx Pharmaceuticals Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Acelrx Pharmaceuticals Inc. in the next few years
Performance of Acelrx Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Acelrx Pharmaceuticals Inc. | -1.880% | 0.631% | 34.069% | 9.866% | 35.437% | -63.778% | -53.004% |
| Concert Pharmaceuticals Inc. | -1.680% | 9.317% | 12.102% | -57.073% | -64.264% | -78.285% | -67.570% |
| Eiger Biopharmaceuticals Inc | -0.530% | 3.950% | -0.074% | -24.607% | -20.592% | -44.910% | -66.650% |
| Heron Therapeutics Inc. | 1.530% | 14.367% | 14.167% | -22.066% | -28.252% | - | - |
Comments
Other discussions about Acelrx Pharmaceuticals Inc. Stock
Trading Acelrx Pharmaceuticals Inc.
Trading Acelrx Pharmaceuticals Inc.
